Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,410.00
Bid: 6,350.00
Ask: 6,370.00
Change: 40.00 (0.63%)
Spread: 20.00 (0.315%)
Open: 6,370.00
High: 6,410.00
Low: 6,350.00
Prev. Close: 6,370.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Nov 2021 07:00

RNS Number : 4232R
4imprint Group PLC
05 November 2021
 

5 November 2021

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides an update on the Group's trading and operations.

 

The Group has made further encouraging progress against the backdrop of continuing uncertain and volatile market conditions.

 

In our Interim results, released on 11 August 2021, we noted that demand activity in June and July 2021 had made a good recovery, with order counts running at around 100% of the 2019 comparative, (the most recent 'normal' year). In the second half of the year to the end of October, weekly order totals have averaged 2% above 2019 levels despite our primary US market being impacted by the Delta variant.

 

Customer acquisition has remained strong, with new customer orders since the half year up 8% over the same period in 2019. This gives us confidence that the significant adjustments made to the marketing mix over the course of the pandemic have worked well, further strengthening our position in the market looking forward.

 

Pandemic-related global and local supply chain issues continue to cause inventory availability challenges, increased production times and product cost inflation in the second half of 2021. Our team is working to address these challenges wherever possible through sourcing alternative products for our customers from our wide range and, as our visibility improves, using price adjustments and other creative strategies to help mitigate cost pressure.

 

The Group remains in a strong financial position, with a cash balance of $41.9m at the October 2021 accounting month end after payment of the Interim dividend in September.

 

We remain very confident in the Group's strategy, business model and competitive position. The demand numbers so far in the second half of 2021 show clearly that our offering continues to resonate with our target customers.

 

Notwithstanding the ongoing market uncertainties, the Board expects that the Group's full year financial performance will be in line with expectations.

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0)20 3709 9680

E-mail hq@4imprint.co.uk

MHP Communications

Tel. + 44 (0)20 3128 8794

E-mail 4imprint@mhpc.com

 

Kevin Lyons-Tarr, Chief Executive Officer

David Seekings, Chief Financial Officer

 

Katie Hunt

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKQBQOBDDDDK
Date   Source Headline
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn
19th Jul 20227:00 amRNSTrading Statement
7th Jul 20222:26 pmRNSHolding(s) in Company
24th Jun 20229:37 amRNSEBT Purchase
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.